MCID: AGN002
MIFTS: 61

Agnosia

Categories: Rare diseases, Eye diseases, Mental diseases

Aliases & Classifications for Agnosia

MalaCards integrated aliases for Agnosia:

Name: Agnosia 12 49 50 28 41 14 69
Primary Visual Agnosia 49 69
Dyspraxia 12 50
Apraxias 41 69
Monomodal Visual Amnesia 49
Dyspraxia Syndrome 12
Visual Amnesia 49
Alexia 69

Classifications:



Summaries for Agnosia

NIH Rare Diseases : 49 Agnosia is characterized by an inability to recognize and identify objects and/or persons. Symptoms may vary, according to the area of the brain that is affected. It can be limited to one sensory modality such as vision or hearing; for example, a person may have difficulty in recognizing an object as a cup or identifying a sound as a cough. Agnosia can result from strokes, traumatic brain injury, dementia, a tumor, developmental disorders, overexposure to environmental toxins (e.g., carbon monoxide poisoning), or other neurological conditions. Visual agnosia may also occur in association with other underlying disorders. People with agnosia may retain their cognitive abilities in other areas. Treatment of primary agnosia is symptomatic and supportive; when it is caused by an underlying disorder, treatment of the disorder may reduce symptoms and help prevent further brain damage. Last updated: 4/22/2011

MalaCards based summary : Agnosia, also known as primary visual agnosia, is related to pain agnosia and visual agnosia, and has symptoms including symptoms, hot flushes and other symbolic dysfunction. An important gene associated with Agnosia is TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1), and among its related pathways/superpathways are Signaling by GPCR and Peptide ligand-binding receptors. The drugs Ketamine and Nalbuphine have been mentioned in the context of this disorder. Affiliated tissues include brain, parietal lobe and temporal lobe, and related phenotypes are behavior/neurological and homeostasis/metabolism

NINDS : 50 Agnosia is a rare disorder characterized by an inability to recognize and identify objects or persons. People with agnosia may have difficulty recognizing the geometric features of an object or face or may be able to perceive the geometric features but not know what the object is used for or whether a face is familiar or not. Agnosia can be limited to one sensory modality such as vision or hearing. For example, a person may have difficulty in recognizing an object as a cup or identifying a sound as a cough. Agnosia can result from strokes, dementia, developmental disorders, or other neurological conditions. It typically results from damage to specific brain areas in the occipital or parietal lobes of the brain. People with agnosia may retain their cognitive abilities in other areas.

Disease Ontology : 12 A communication disorder that is a loss of ability to recognize objects, persons, sounds, shapes, or smells while the specific sense is not defective nor is there any significant memory loss.

Wikipedia : 72 Agnosia is the inability to process sensory information. Often there is a loss of ability to recognize... more...

Related Diseases for Agnosia

Diseases in the Agnosia family:

Form Agnosia

Diseases related to Agnosia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 121)
# Related Disease Score Top Affiliating Genes
1 pain agnosia 29.2 AP1M2 AP2M1 CCK CNR1 HTR7 LIPN
2 visual agnosia 12.4
3 auditory agnosia 12.3
4 apperceptive agnosia 12.3
5 rolandic epilepsy, mental retardation, and speech dyspraxia, x-linked 12.3
6 verbal auditory agnosia 12.3
7 finger agnosia 12.3
8 developmental dyspraxia 12.2
9 integrative agnosia 12.2
10 tactile agnosia 12.2
11 form agnosia 12.2
12 topographical agnosia 12.2
13 social emotional agnosia 12.2
14 associative agnosia 12.2
15 mirror agnosia 12.1
16 visual verbal agnosia 12.1
17 semantic agnosia 12.1
18 time agnosia 12.1
19 color agnosia 12.0
20 rolandic epilepsy-speech dyspraxia syndrome 11.9
21 astereognosia 11.8
22 autotopagnosia 11.4
23 cortical deafness 11.3
24 gerstmann syndrome 11.3
25 prosopagnosia 11.3
26 apraxia 11.2
27 alexia 11.2
28 phonagnosia 11.1
29 alexithymia 11.1
30 amusia 11.1
31 anosognosia 11.1
32 agraphia 11.1
33 achromatopsia 11.1
34 simultanagnosia 11.1
35 akinetopsia 10.8
36 kluver-bucy syndrome 10.8
37 nominal aphasia 10.8
38 cyclic vomiting syndrome 10.5 CNR1 OPRM1
39 myofascial pain syndrome 10.5 POMC TAC1
40 autoimmune encephalitis 10.5 CNR1 TRPV1
41 sick building syndrome 10.5 POMC TRPV1
42 epicondylitis 10.5 LIPN TAC1
43 retrograde amnesia 10.5 PDYN POMC
44 neonatal abstinence syndrome 10.5 OPRK1 OPRM1
45 somatoform disorder 10.5 OPRM1 TAC1 TRPV1
46 stereotypic movement disorder 10.5 CCK TAC1
47 chronic pain 10.5 CNR1 OPRM1
48 trigeminal nerve disease 10.5 LIPN TAC1 TRPV1
49 pancreas disease 10.4 CCK POMC TRPV1
50 functional gastric disease 10.4 CCK HTR7 TRPV1

Graphical network of the top 20 diseases related to Agnosia:



Diseases related to Agnosia

Symptoms & Phenotypes for Agnosia

UMLS symptoms related to Agnosia:


symptoms, hot flushes, other symbolic dysfunction, abnormality of extrapyramidal motor function, clumsiness, vertigo, torticollis, syncope, signs and symptoms, digestive, signs and symptoms, seizures, muscle rigidity, icterus, headache, fever, edema, dyspnea, cyanosis, cachexia, scanning speech, visual agnosia

MGI Mouse Phenotypes related to Agnosia:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.03 OPRM1 OXT PDYN PNOC POMC TAC1
2 homeostasis/metabolism MP:0005376 9.93 AP1M2 CCK CNR1 HTR7 LIPN OPRK1
3 adipose tissue MP:0005375 9.8 CNR1 OPRM1 OXT PDYN POMC TRPV1
4 integument MP:0010771 9.7 CNR1 HTR7 OPRK1 OPRL1 OPRM1 OXT
5 nervous system MP:0003631 9.32 OPRK1 OPRL1 OPRM1 OXT PDYN POMC

Drugs & Therapeutics for Agnosia

Drugs for Agnosia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 112)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
2
Nalbuphine Approved Phase 4 20594-83-6 5311304 5360630
3
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
4
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
5
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
6
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
7
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 137-58-6 3676
8
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 5311068 56032 68602
9
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
10
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
11
Acetaminophen Approved Phase 4,Phase 2,Phase 3 103-90-2 1983
12
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
13
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
14
Ibuprofen Approved Phase 4 15687-27-1 3672
15
Clonidine Approved Phase 4 4205-90-7 2803
16
Tramadol Approved, Investigational Phase 4,Phase 3 27203-92-5 33741
17
Ropivacaine Approved Phase 4,Phase 3 84057-95-4 175805 71273
18
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
19
Dezocine Approved, Investigational Phase 4 53648-55-8 3033053 40841
20
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
21
Remifentanil Approved Phase 4,Phase 3 132875-61-7 60815
22
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
23 Nefopam Approved, Investigational Phase 4 13669-70-0
24
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
25 Analgesics Phase 4,Phase 3,Phase 2
26 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2
27 Anesthetics, Dissociative Phase 4
28 Anesthetics, General Phase 4,Phase 3
29 Anesthetics, Intravenous Phase 4,Phase 3
30 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1
31 Excitatory Amino Acid Antagonists Phase 4
32 Excitatory Amino Acids Phase 4
33 Neurotransmitter Agents Phase 4
34 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
35 Analgesics, Opioid Phase 4,Phase 3,Phase 2
36 Narcotics Phase 4,Phase 3,Phase 2
37 Anti-Inflammatory Agents Phase 4
38 BB 1101 Phase 4
39 Dexamethasone acetate Phase 4 1177-87-3
40 Anesthetics, Local Phase 4,Phase 3,Phase 1,Phase 2
41 Autonomic Agents Phase 4
42 Antiemetics Phase 4
43 Antineoplastic Agents, Hormonal Phase 4
44 Gastrointestinal Agents Phase 4
45 glucocorticoids Phase 4
46 HIV Protease Inhibitors Phase 4
47 Hormone Antagonists Phase 4
48 Hormones Phase 4
49 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
50
protease inhibitors Phase 4

Interventional clinical trials:

(show top 50) (show all 63)

# Name Status NCT ID Phase Drugs
1 Ketamine and Postoperative Analgesia in Children Unknown status NCT00200564 Phase 4 ketamine
2 The Combination Effect of Dexmedetomidine and Morphine in Postoperative Patient-Controlled Analgesia Completed NCT00800826 Phase 4 dexmedetomidine
3 Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia Completed NCT02516059 Phase 4 oxycodone/naloxone;Oxycodone;Placebo
4 Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery Completed NCT01966172 Phase 4 Ibuprofen;Gabapentin;Morphine;Paracetamol
5 Postoperative Pain and SIRS After Preoperative Analgesia With Clonidine or Levobupivacaine Completed NCT00860899 Phase 4 clonidine, levobupivacaine
6 Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy Completed NCT00564603 Phase 4 Dexamethasone Sodium Phosphate Injection
7 Effect of Dexmedetomidine for Postoperative Intravenous Patient Controlled Analgesia Recruiting NCT03014713 Phase 4 Dezocine;Flubiprofen;Dexmedetomidine
8 Dexmedetomidine Supplemented Analgesia and 3-Year Survival After Cancer Surgery Recruiting NCT03012971 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
9 Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium Recruiting NCT03012984 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
10 Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks Enrolling by invitation NCT02523235 Phase 4 ropivacaine 0.2%
11 Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections Not yet recruiting NCT03105193 Phase 4 IV Saline bolus and infusion;IP Saline bolus and infusion;IV lignocaine bolus and infusion;IP Lignocaine bolus and infusion
12 Intrathecal Morphine Analgesia vs. Continuous Epidural Analgesia vs. Systemic Analgesia in Colorectal Surgery. Not yet recruiting NCT03007121 Phase 4 Morphine intrathecal;Bupivacaine + Sufentanil epidural;Morphine intravenous
13 Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia. Terminated NCT01882530 Phase 4 Paracetamol;Nefopam;Ketoprofen;Morphine
14 A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. Terminated NCT00421720 Phase 4 Sufentanil;Remifentanil
15 Combination Analgesia for Neonatal Circumcision Completed NCT02990364 Phase 3 Sucrose;Lidocaine;EMLA Topical Product
16 Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia Completed NCT02264821 Phase 3 ropivacaine infiltration;intrathecal morphine;placebo
17 Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants Completed NCT00713726 Phase 3 FentanyL;Tramadol
18 Continuous Regional Analgesia After Total Knee Arthroplasty Completed NCT00337597 Phase 3
19 A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia Recruiting NCT02811991 Phase 2, Phase 3 Paracetamol injection;Normal Saline injection;Morhpine PCA
20 Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU) Terminated NCT00436345 Phase 3 Remifentanil;Propofol
21 Development of a New Method for Analgesia Completed NCT00791024 Phase 1, Phase 2 CRC-Pharma 001;lidocaine suspension
22 Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia Unknown status NCT01739270
23 Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients Unknown status NCT01553435 Dextromethorphan;Placebo
24 Do Epidurals Placed at a Lower Level Improve Labor Analgesia? Unknown status NCT00954317
25 Depodur vs Fentanyl Infusion for Post-C/S Analgesia Unknown status NCT00762554 Depodur;Depodur;Fentanyl
26 Low Level Laser (LED) Use to Increase Dental Implant Stability and Post Operative Analgesia Unknown status NCT01097499
27 Effect of Thoracic Epidural Analgesia for Thoracotomy on the Occurrence of AF Unknown status NCT01718717
28 Postoperative Patient-controlled Perineural Analgesia After Orthopedic Surgery by "Remote Control" Versus "Bedside Care" Unknown status NCT02018068
29 Perception and Multisensory Integration in Neurological Patients Using fMRI Unknown status NCT01469858
30 Orientation Agnosia: Clinical and Anatomical Study Completed NCT01304576
31 Newborn Cortical Response to Pain and Non Pharmacological Analgesia Completed NCT03389789
32 Comparison of Patient-Controlled Analgesia With Different Background Infusion Completed NCT03221491
33 Individualized Analgesia on Respiratory Adverse Events After Adenotonsillectomy Completed NCT02990910 personalized opioid analgesia
34 A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT02104934
35 μ-opioid Receptor Polymorphism and Opioid Analgesia Completed NCT02099877 Fentanyl
36 The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers Completed NCT01886014 Oxytocin
37 Labour Analgesia and Movement in Babies Completed NCT01280084
38 The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT) Completed NCT01261689 Ropivacaine/ Sufentanil according to local hospital protocol
39 Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia Completed NCT00487084 Morphine-CP-saline (MCS);saline-2CP-morphine (SCM);saline-lidocaine-morphine (SLM)
40 Individualized Timing of Analgesia and Effectiveness of Labor Analgesia Completed NCT02920489 Individualized epidural analgesia;Routine epidural analgesia
41 Epidural Analgesia in Intensive Care Unit (APD-REA: Analgesie PeriDurale en REAnimation) Completed NCT01437358
42 Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled Study Completed NCT01220362 Bupivacain 0.125%;Bupivacain 0.125%/Fentanyl 2mcg/ml
43 Surgical Stress Index as a Tool for Monitoring Analgesia and/or Sedation in Critically Ill Patients Completed NCT00789412
44 Telemedically Supported Analgesia in the Emergency Medical Service Completed NCT01644032
45 Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Completed NCT00908999
46 Neuraxial Labor Analgesia and the Incidence of Postpartum Depression Completed NCT02823418
47 Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty Recruiting NCT03203967 Intravenous morphine analgesia
48 Perfusion Index and Labor Analgesia Recruiting NCT03107559
49 Combined Implementation of Dural Puncture Epidural and Programmed Intermittent Epidural Bolus for Labor Analgesia Recruiting NCT03366935
50 Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson's Recruiting NCT02561715

Search NIH Clinical Center for Agnosia

Cochrane evidence based reviews: agnosia

Genetic Tests for Agnosia

Genetic tests related to Agnosia:

# Genetic test Affiliating Genes
1 Agnosia 28

Anatomical Context for Agnosia

MalaCards organs/tissues related to Agnosia:

38
Brain, Parietal Lobe, Temporal Lobe, Colon, Cortex, Eye, T Cells

Publications for Agnosia

Articles related to Agnosia:

(show top 50) (show all 420)
# Title Authors Year
1
The neuropsychological rehabilitation of visual agnosia and Balint's syndrome. ( 29366371 )
2018
2
Impaired peripheral reaching and on-line corrections in patient DF: Optic ataxia with visual form agnosia. ( 28532578 )
2017
3
Auditory agnosia caused by bilateral putamen haemorrhage. ( 29269367 )
2017
4
Evidence of taxonomy for Developmental Topographical Disorientation: Developmental Landmark Agnosia Case 1. ( 29192795 )
2017
5
Pure Amorphagnosia without Tactile Object Agnosia. ( 28559827 )
2017
6
Landmark Agnosia: Evaluating the Definition of Landmark-based Navigation Impairment. ( 28164221 )
2017
7
Relationship between somatosensory event-related potential N140 aberrations and hemispatial agnosia in patients with stroke: a preliminary study. ( 29076767 )
2017
8
Preserved Expert Object Recognition in a Case of Unilateral Visual Agnosia. ( 28949822 )
2017
9
Congenital prosopagnosia without object agnosia? A literature review. ( 29165034 )
2017
10
The painter from Sinaloa: artistic analysis of a case of spatial agnosia and neglect of visual shapes. ( 29185377 )
2017
11
Auditory agnosia associated with bilateral putaminal hemorrhage: A case report of clinical course of recovery. ( 28740065 )
2017
12
Stroke of the inferiomedial temporal lobe causing word agnosia. ( 28747411 )
2017
13
Visual agnosia and focal brain injury. ( 28843416 )
2017
14
Pearls & Oy-sters: Visual agnosia: An overlooked cortical sign. ( 27821572 )
2016
15
Hurt but still alive: Residual activity in the parahippocampal cortex conditions the recognition of familiar places in a patient with topographic agnosia. ( 26909331 )
2016
16
Enhancing Diversity in Academic Neurology: From Agnosia to Action. ( 26972163 )
2016
17
Emotional quotient in frontotemporal dementia vs. Alzheimer's disease: the role of socioemotional agnosia. ( 27903133 )
2016
18
Poster 215 Gustatory Agnosia Following Herpes Simplex Virus Encephalitis: A Case Report. ( 27672976 )
2016
19
Functional dissociation between action and perception of object shape in developmental visual object agnosia. ( 26827163 )
2016
20
What's in the name 'alexithymia'? A commentary on "Affective agnosia: Expansion of the alexithymia construct and a new opportunity to integrate and extend Freud's legacy.". ( 27235080 )
2016
21
Agnosia for head tremor in essential tremor: prevalence and clinical correlates. ( 26877883 )
2016
22
Impaired Velocity Processing Reveals an Agnosia for Motion in Depth. ( 27677897 )
2016
23
Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient. ( 26035220 )
2015
24
Visual processing of words in a patient with visual form agnosia: a behavioural and fMRI study. ( 25461705 )
2015
25
Pure word deafness with auditory object agnosia after bilateral lesion of the superior temporal sulcus. ( 26343343 )
2015
26
Visual agnosia. ( 26358494 )
2015
27
Which visual functions depend on intermediate visual regions? Insights from a case of developmental visual form agnosia. ( 26209358 )
2015
28
Reprint of: Visual processing of words in a patient with visual form agnosia: A behavioural and fMRI study. ( 26475097 )
2015
29
Affective agnosia: Expansion of the alexithymia construct and a new opportunity to integrate and extend Freud's legacy. ( 26054794 )
2015
30
Simultanagnosia and scene agnosia induced by right posterior cerebral artery infarction: a case report. ( 26369377 )
2015
31
Auditory agnosia. ( 25726291 )
2015
32
Real-time vision, tactile cues, and visual form agnosia: removing haptic feedback from a "natural" grasping task induces pantomime-like grasps. ( 25999834 )
2015
33
Tactile Toe Agnosia and Percept of a "Missing Toe" in Healthy Humans. ( 26562866 )
2015
34
Functional Mapping of the Human Auditory Cortex: fMRI Investigation of a Patient with Auditory Agnosia from Trauma to the Inferior Colliculus. ( 26413744 )
2015
35
Intact implicit representation of object 3D structure in object agnosia. ( 26326787 )
2015
36
Pure associative tactile agnosia for the left hand: clinical and anatomo-functional correlations. ( 25046697 )
2014
37
Visual object agnosia is associated with a breakdown of object-selective responses in the lateral occipital cortex. ( 24863251 )
2014
38
Training-induced recovery of low-level vision followed by mid-level perceptual improvements in developmental object and face agnosia. ( 24698161 )
2014
39
The mitochondrial DNA 10197 Ga88>a88A mutation causes MELAS/Leigh overlap syndrome presenting with acute auditory agnosia. ( 24708134 )
2014
40
Agnosia for mirror stimuli: a new case report with a small parietal lesion. ( 25037846 )
2014
41
When apperceptive agnosia is explained by a deficit of primary visual processing. ( 24607265 )
2014
42
Selective preservation of the beat in apperceptive music agnosia: a case study. ( 24561388 )
2014
43
Agnosia in Canon: a Historical Issue. ( 26110161 )
2014
44
Delayed action does not always require the ventral stream: a study on a patient with visual form agnosia. ( 24657477 )
2014
45
Episodic epileptic verbal auditory agnosia in Landau Kleffner syndrome treated with combination diazepam and corticosteroids. ( 24453158 )
2014
46
Mirror image agnosia. ( 25336773 )
2014
47
Neurodegeneration and mirror image agnosia. ( 25317393 )
2014
48
Patient DF's visual brain in action: Visual feedforward control in visual form agnosia. ( 25199609 )
2014
49
Auditory agnosia as a clinical symptom of childhood adrenoleukodystrophy. ( 25544384 )
2014
50
Psychosis, agnosia, and confabulation: an alternative two-factor account. ( 24328860 )
2014

Variations for Agnosia

Expression for Agnosia

Search GEO for disease gene expression data for Agnosia.

Pathways for Agnosia

GO Terms for Agnosia

Cellular components related to Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.91 CNR1 HTR7 OPRK1 OPRL1 OPRM1 PSENEN
2 neuron projection GO:0043005 9.78 OPRK1 OPRL1 OPRM1 TRPV1
3 axon GO:0030424 9.73 CCK CNR1 OPRM1 TAC1
4 neuronal cell body GO:0043025 9.63 CCK OPRK1 PDYN PNOC TAC1 TRPV1
5 perikaryon GO:0043204 9.56 CCK NPFF OPRK1 OPRM1
6 terminal bouton GO:0043195 9.5 AP2M1 CCK OXT
7 clathrin adaptor complex GO:0030131 9.4 AP1M2 AP2M1
8 axon terminus GO:0043679 9.26 NPFF OPRK1 PDYN PNOC
9 dendrite GO:0030425 9.17 CCK NPFF OPRK1 OPRM1 PDYN PNOC
10 plasma membrane GO:0005886 10.23 AP2M1 CNR1 HTR7 OPRK1 OPRL1 OPRM1

Biological processes related to Agnosia according to GeneCards Suite gene sharing:

(show all 32)
# Name GO ID Score Top Affiliating Genes
1 chemical synaptic transmission GO:0007268 9.92 HTR7 NPFF OPRK1 OPRL1 OPRM1 PDYN
2 positive regulation of cytosolic calcium ion concentration GO:0007204 9.89 NPFF OPRL1 OXT TAC1 TRPV1
3 response to morphine GO:0043278 9.83 CNR1 NPFF OPRK1 OPRM1 TAC1
4 response to ethanol GO:0045471 9.82 CNR1 OPRK1 OPRM1
5 eating behavior GO:0042755 9.8 CCK OPRK1 OPRL1 OPRM1 OXT
6 excitatory postsynaptic potential GO:0060079 9.79 NPFF OPRM1 TRPV1
7 adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway GO:0007193 9.77 OPRK1 OPRL1 OPRM1
8 G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger GO:0007187 9.76 CNR1 HTR7 OPRM1
9 response to cocaine GO:0042220 9.76 CNR1 OPRK1 OPRM1 OXT
10 negative regulation of blood pressure GO:0045776 9.75 CNR1 OPRL1 OXT
11 sensory perception of pain GO:0019233 9.73 CNR1 OPRK1 OPRL1 OPRM1 TAC1 TRPV1
12 positive regulation of blood pressure GO:0045777 9.7 CNR1 NPFF OXT
13 estrous cycle GO:0044849 9.69 OPRK1 OPRL1 OPRM1
14 response to food GO:0032094 9.65 OPRM1 OXT
15 response to pain GO:0048265 9.65 TAC1 TRPV1
16 opioid receptor signaling pathway GO:0038003 9.65 OPRK1 OPRL1 OPRM1
17 negative regulation of cAMP biosynthetic process GO:0030818 9.64 OPRL1 OPRM1
18 positive regulation of ossification GO:0045778 9.64 OXT TAC1
19 positive regulation of renal sodium excretion GO:0035815 9.63 OXT TAC1
20 maternal behavior GO:0042711 9.63 OPRK1 OXT
21 behavior GO:0007610 9.62 OPRK1 OPRL1
22 negative regulation of heart rate GO:0010459 9.62 NPFF TAC1
23 negative regulation of appetite GO:0032099 9.61 CCK NPFF
24 acute inflammatory response to antigenic stimulus GO:0002438 9.6 NPFF OPRM1
25 adenylate cyclase-inhibiting opioid receptor signaling pathway GO:0031635 9.55 OPRK1 OPRM1
26 sensory perception GO:0007600 9.55 OPRK1 OPRL1 OPRM1 PDYN PNOC
27 positive regulation of gastric acid secretion GO:0060454 9.54 OPRL1 TRPV1
28 regulation of sensory perception of pain GO:0051930 9.43 CCK NPFF OPRK1 OPRL1 OPRM1 OXT
29 neuropeptide signaling pathway GO:0007218 9.23 NPFF OPRK1 OPRL1 OPRM1 PDYN PNOC
30 signal transduction GO:0007165 10.27 CCK CNR1 HTR7 OPRK1 OPRL1 OPRM1
31 G-protein coupled receptor signaling pathway GO:0007186 10.15 CCK CNR1 HTR7 NPFF OPRK1 OPRL1
32 regulation of receptor activity GO:0010469 10.03 CCK NPFF OXT PDYN PNOC POMC

Molecular functions related to Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.54 CCK OXT POMC
2 neuropeptide binding GO:0042923 9.33 OPRK1 OPRL1 OPRM1
3 opioid receptor binding GO:0031628 9.32 PDYN PNOC
4 opioid peptide activity GO:0001515 9.26 PDYN PNOC
5 opioid receptor activity GO:0004985 9.13 OPRK1 OPRL1 OPRM1
6 neuropeptide hormone activity GO:0005184 9.1 CCK NPFF OXT PDYN PNOC POMC

Sources for Agnosia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....